Compare American Express Co (AXP) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
American Express Co vs Recursion Pharmaceuticals Inc — how do they compare? American Express Co trades at $340.05 (market cap $230.15B), while Recursion Pharmaceuticals Inc trades at $3.37 (market cap $1.81B). The key difference: American Express Co is far larger — about 127.2× Recursion Pharmaceuticals Inc's market cap, and American Express Co pays a 1.11% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AXP | RXRX | |
|---|---|---|
Market Cap | $230.15B | $1.81B |
Sector | Financials | Health |
52-Week High | $384.82 | $6.79 |
52-Week Low | $292.27 | $2.84 |
Dividend Yield | 1.11% | — |
Enterprise Value | — | $1.33B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About American Express Co
American Express Company is a global payment and travel company. The Company's principal products and services are charge and credit payment card products and travel-related services offered to consumers and businesses around the world.
Read more on AXP →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
